Back to top

Image: Bigstock

The Zacks Analyst Blog Highlights: Nike, CVS Health, American Tower Corp, The Southern Co, American International Group and Parker-Hannifin Corp

Read MoreHide Full Article

For Immediate Release

Chicago, IL – May 11, 2021 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Nike, Inc. (NKE - Free Report) , CVS Health Corporation (CVS - Free Report) , American Tower Corporation (AMT - Free Report) , The Southern Company (SO - Free Report) , American International Group, Inc. (AIG - Free Report) and Parker-Hannifin Corporation (PH - Free Report) .

Here are highlights from Monday’s Analyst Blog:

Top Stock Reports for Nike, CVS Health and American Tower

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Nike, CVS Health Corp., and American Tower Corp. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.

You can see all of today's research reports here >>>

Shares of Nike have underperformed the Zacks Shoes and Retail Apparel industry over the last three months (-3.9% vs -1.7%). The Zacks analyst believes that the company has been witnessing lower revenues at the wholesale business and NIKE-owned stores due to the pandemic-led disruptions. Apparently, revenues lagged the Zacks Consensus Estimate in third-quarter fiscal 2021. In fact, revenues declined across all the regions, except for Greater China.

Nonetheless, the top and bottom line improved year over year in third quarter, while earnings beat estimates for the third time. Impressively, digital sales of the NIKE brand improved double digits across North America, Greater China, and APLA along with triple-digit growth in EMEA.

(You can read the full research report on NIKE here >>>)

Shares of CVS Health have outperformed the Zacks Retail - Pharmacies and Drug Stores industry over the last three months (+15.7% vs +11.9%). CVS Health's first-quarter earnings and revenues surpassed the respective Zacks Consensus Estimate. Revenues across all the three operating segments improved reporting better than the company's expectations. In fact, the Zacks analyst believes that increased full-year guidance is indicative of this bullish trend to continue through the rest of 2021.

The company noted that consumer-centric digital strategy has become more relevant in the current environment as people are using technology more while staying indoors. In the first quarter, the company has achieved higher levels of engagement across digital assets. However, a weak cough, cold and flu season impacted growth within both Pharmacy Services and Retail/LTC. Also, the repeal of the HIF for 2021 hampered growth for Health Care Benefits.

(You can read the full research report on CVS Health here >>>)

American Tower shares have gained +8.6% over the last three months against the Zacks REIT and Equity Trust – Other industry's gain of +8.8%. The Zacks analyst believes that the company's decent first-quarter results were supported by organic tenant billing growth. Going forward, American Tower's extensive and geographically diversified communication real estate portfolio is well-poised to benefit from increasing capital spending by wireless carriers in 5G deployments and future deployment of additional spectrum.

However, its shares have underperformed the industry over the past three months. Also, the company expects a churn rate in its U.S. & Canada property segment to be elevated for several years, affecting overall organic tenant billing growth.

(You can read the full research report on American Tower here >>>)

Other noteworthy reports we are featuring today include The Southern Co., American International Group and Parker-Hannifin Corp.

Zacks Top 10 Stocks for 2021

In addition to the stocks discussed above, would you like to know about our 10 best buy-and-hold tickers for the entirety of 2021?

Last year's 2020 Zacks Top 10 Stocks portfolio returned gains as high as +386.8%. Now a brand-new portfolio has been handpicked from over 4,000 companies covered by the Zacks Rank. Don't miss your chance to get in on these long-term buys.

Access Zacks Top 10 Stocks for 2021 today >>

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com                                      

https://www.zacks.com                                          

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.